Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore Cabenuva, a long-acting injectable HIV treatment option. Learn about its dosage, administration, benefits, and suitability for patients in India.
In the ongoing battle against Human Immunodeficiency Virus (HIV), advancements in treatment have been a beacon of hope. Traditional HIV therapies often involve daily oral medications, which, while effective, can present challenges for some individuals regarding adherence and lifestyle integration. Cabenuva, a groundbreaking medication, offers a novel solution by providing a long-acting injectable option for HIV treatment. This article delves into the specifics of Cabenuva, its dosage, administration, and its significance for patients in India.
Cabenuva is a prescription medication used to treat HIV in adults and children aged 12 years and older who weigh at least 77 pounds (approximately 35 kg). It is a combination of two antiretroviral drugs: cabotegravir and rilpivirine. Unlike daily pills, Cabenuva is administered as two separate intramuscular injections into the gluteal (buttock) muscle by a qualified healthcare professional. The 'extended-release' formulation ensures that the active ingredients are slowly released into the body over time, allowing for less frequent dosing.
Cabotegravir and rilpivirine are antiretroviral agents that work by inhibiting the replication of the HIV virus. Cabotegravir is an integrase strand transfer inhibitor (INSTI), while rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). By blocking different stages of the HIV life cycle, these drugs effectively reduce the viral load in the body, helping to maintain immune system health and prevent the progression of HIV to AIDS.
The dosage and schedule for Cabenuva are tailored to individual patient needs and preferences, in consultation with a healthcare provider. There are two primary dosing schedules:
For patients on a monthly dosing schedule:
For patients opting for the every two months dosing schedule:
Important Considerations for Administration:
Before starting Cabenuva injections, your doctor may prescribe oral tablets of cabotegravir (Vocabria) and rilpivirine (Edurant) for you to take daily for at least 28 days. This 'oral lead-in' period allows your doctor to assess how your body tolerates these medications and to ensure there are no adverse reactions before transitioning to the injectable form. This step is vital for ensuring the safety and efficacy of the long-acting treatment.
Cabenuva is available in two strengths, corresponding to the different dosing requirements:
The specific strength used depends on the dosing schedule (monthly or every two months) and the phase of treatment (initiation or maintenance).
Cabenuva is indicated for individuals with HIV who:
Cabenuva offers several potential benefits:
As with any medication, Cabenuva can have side effects. The most common side effects are injection site reactions, such as pain, swelling, redness, or itching. Other potential side effects may include fatigue, headache, nausea, and dizziness. Serious side effects, though rare, can occur and may include allergic reactions or liver problems. It is essential to discuss any concerns with your healthcare provider.
Consistent adherence to the Cabenuva dosing schedule is paramount for maintaining viral suppression and preventing the development of drug resistance. Missing doses can lead to an increase in viral load and potentially make the virus harder to treat. If you anticipate missing an appointment or have missed a dose, it is crucial to contact your doctor immediately to discuss the best course of action. Regular follow-up appointments are also necessary for monitoring your health, viral load, and potential side effects.
The introduction of long-acting injectable options like Cabenuva marks a significant step forward in HIV management in India. While access and availability may vary, this treatment modality offers a promising alternative for individuals seeking more convenient and discreet ways to manage their HIV. As the healthcare landscape evolves, such innovations have the potential to improve the quality of life for many living with HIV in India.
You should consult your doctor if:
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026